MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, CYCN has $10,415K in assets. $4,568K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
577.54%
Cash Ratio
520.87%
Assets Breakdown
    • Other investment
    • Cash and cash equivalents
    • Prepaid expenses
    • Others
Liabilities Breakdown
    • Paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
2024-12-31
Cash and cash equivalents
4,568 3,006 3,232
Accounts receivable
100 525 556
Prepaid expenses
386 462 421
Other current assets
11 27 16
Total current assets
5,065 4,020 4,225
Other investment
5,350 5,350 5,350
Total assets
10,415 9,370 9,575
Accounts payable
480 462 390
Accrued research and development costs
46 72 52
Accrued expenses and other current liabilities
351 266 283
Total current liabilities
877 800 725
Preferred stock, no par value, 100,000,000 shares authorized and 351,037 shares of series a convertible preferred stock issued and outstanding at september 30, 2025 and december 31, 2024
0 0 0
Common stock, no par value, 400,000,000 shares authorized at september 30, 2025 and december 31, 2024 3,814,260 and 2,710,096 shares issued at september 30, 2025 and december 31, 2024, respectively 3,695,158 and 2,545,922 shares outstanding at september 30, 2025 and december 31,2024, respectively
0 0 0
Paid-in capital
279,759 277,815 276,342
Accumulated deficit
-270,221 -269,245 -267,492
Accumulated other comprehensive loss
--0
Total stockholders' equity
9,538 8,570 8,850
Total liabilities and stockholders' equity
10,415 9,370 9,575
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Other current assets$11K Prepaid expenses$386K Accounts receivable$100K Cash and cashequivalents$4,568K Other investment$5,350K Total current assets$5,065K Total assets$10,415K Total liabilities andstockholders' equity$10,415K Total stockholders'equity$9,538K Total currentliabilities$877K Accumulated deficit-$270,221K Paid-in capital$279,759K Accrued expenses andother current...$351K Accrued research anddevelopment costs$46K Accounts payable$480K

Cyclerion Therapeutics, Inc. (CYCN)

Cyclerion Therapeutics, Inc. (CYCN)